Renub Research Forecasts Robust Growth as Demand for Continuous Glucose Monitoring and Insulin Delivery Devices Surges Nationwide
According to the latest analysis by Renub Research, the United States Diabetes Device Market is forecasted to grow from US$ 8.67 Billion in 2023 to a remarkable US$ 16.25 Billion by 2032, with a Compound Annual Growth Rate (CAGR) of 7.23% during the forecast period 2024–2032. The rapid rise in market value is driven by increasing diabetes prevalence, a growing elderly population, innovations in continuous glucose monitoring (CGM), and insulin delivery technologies, along with higher awareness and government initiatives focused on diabetes management.
? Access the full report: United States Diabetes Device Market
Alarming Rise in Diabetes Cases Fuels Device Demand
The United States is witnessing a sharp increase in the number of individuals diagnosed with type 1 and type 2 diabetes, largely due to sedentary lifestyles, poor dietary habits, obesity, and genetic predispositions. According to the Centers for Disease Control and Prevention (CDC), over 37 million Americans (approximately 11% of the population) currently live with diabetes. This figure is expected to rise in the coming decade, placing immense pressure on the healthcare system and increasing reliance on advanced diabetes monitoring and treatment devices.
Continuous Glucose Monitoring (CGM) Leads the Innovation Wave
Among all diabetes devices, Continuous Glucose Monitoring (CGM) systems are transforming diabetes care. These wearable devices offer real-time glucose level readings, provide trends and alerts, and help patients and caregivers monitor glucose levels more accurately than traditional methods.
Major players like Dexcom, Abbott (Freestyle Libre), and Medtronic are continually innovating CGM devices by introducing longer sensor wear time, smartphone integration, and AI-based analytics to improve glycemic control and reduce the risk of hypoglycemia.
Patients with type 1 diabetes and insulin-dependent type 2 diabetes are increasingly adopting CGMs due to:
Reduced finger-prick testing
Real-time glucose insights
Enhanced decision-making for insulin dosing
Smart Insulin Delivery Systems Gaining Ground
Insulin delivery has evolved from traditional syringes to insulin pens, pumps, and patch technologies. These devices enable precise and personalized insulin administration, improving patient adherence and minimizing complications.
The rise of smart insulin pens—which track dose history and connect to smartphone apps—alongside automated insulin delivery (AID) systems (integrating CGM with insulin pumps) is significantly enhancing diabetes management. Companies like Tandem Diabetes Care, Insulet (Omnipod), and Medtronic are advancing insulin pump design, making them more compact, tubeless, and user-friendly.
Integration of Artificial Intelligence and IoT Enhances Diabetes Care
Technological integration is revolutionizing the U.S. diabetes device market. The use of Artificial Intelligence (AI), Internet of Things (IoT), and mobile apps allows:
Predictive analytics to forecast blood glucose trends
Telehealth support for remote monitoring
Personalized treatment plans based on real-time data
Greater patient engagement and education
The increasing use of smartphone-enabled devices that can sync with cloud-based platforms gives patients, caregivers, and healthcare providers seamless access to data for better disease management.
Pediatric and Geriatric Populations Drive Device Adoption
Diabetes among children and adolescents is rising due to poor dietary patterns, obesity, and sedentary habits. CGM systems and patch insulin pumps have proven to be beneficial tools for pediatric diabetes management, providing safe and consistent glucose monitoring while minimizing discomfort.
Simultaneously, the growing elderly population in the U.S.—many of whom suffer from comorbidities—are also strong adopters of automated diabetes devices that offer easier handling and reduce risks of incorrect dosing.
Government Initiatives and Insurance Support Propel Market Growth
Public health bodies and government agencies in the U.S. have implemented several initiatives to raise awareness about diabetes and increase access to advanced diabetes care devices. Key contributors include:
CDC’s National Diabetes Prevention Program
Medicare and Medicaid coverage for CGMs and insulin pumps
U.S. FDA approvals for innovative devices, including hybrid closed-loop systems
Furthermore, reimbursement policies for diabetes devices and inclusion of advanced CGMs in insurance plans have boosted affordability and uptake.
Home Healthcare and Remote Monitoring Trends Reshape Market Dynamics
Post-COVID-19, the U.S. healthcare landscape has experienced a massive shift toward home-based care and remote monitoring, which greatly benefits diabetes patients. Devices enabling self-monitoring of blood glucose (SMBG), app-connected insulin pumps, and CGMs facilitate round-the-clock care without requiring hospital visits.
This has led to increased sales through online pharmacies, DTC (Direct-to-Consumer) platforms, and improved logistics by device manufacturers to reach remote and rural populations.
Competitive Landscape: Leading Players and Innovations
The United States diabetes device market is dominated by several global players known for constant innovation, partnerships with healthcare providers, and direct-to-patient strategies. Key market players include:
Dexcom
Abbott Laboratories
Medtronic
Insulet Corporation
Tandem Diabetes Care
Ascensia Diabetes Care
Roche Diabetes Care
Becton, Dickinson and Company (BD)
These companies are expanding their product lines, improving sensor accuracy, extending device life, and integrating cloud platforms for data sharing and AI-based alerts.
Key Segments in the United States Diabetes Device Market
1. Monitoring Devices
Self-Monitoring of Blood Glucose (SMBG)
Continuous Glucose Monitoring (CGM)
2. Insulin Delivery Devices
Insulin Syringes and Pens
Insulin Pumps
Patch Pumps
3. Smart and Connected Devices
Bluetooth-enabled insulin pens
Smartphone-compatible CGMs
AI-driven data platforms and alerts
Challenges: Data Security, High Costs, and User Training
Despite the positive outlook, certain challenges need to be addressed:
High initial costs of CGMs and insulin pumps can deter adoption among low-income populations
Data privacy concerns associated with smart, cloud-connected devices
Technical literacy and training gaps for elderly or non-tech-savvy patients
Regulatory and reimbursement delays for new device approvals
These issues highlight the need for affordable, accessible, and intuitive solutions tailored to different population segments.
Outlook: A Decade of Growth and Transformation Ahead
The United States Diabetes Device Market is poised for continued expansion, fueled by:
Technological breakthroughs in sensor-based systems
Wider insurance coverage
Telehealth integration
Rising patient awareness and education
By 2032, the U.S. market will reflect a new era in digital diabetes care, where personalized and predictive device ecosystems become the norm, not the exception.
New Publish Report:
- Global Candy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
- Global Cataract Surgery Devices Market Analysis Forecast 2025–2033
- Global Crowdfunding Market Size, Trends Forecast 2025- 2033
About Renub Research
Renub Research is a Market Research and Consulting Company with more than 15 years of experience, especially in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that help companies make better business decisions.
We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele includes key players in Healthcare, Travel Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemicals, Logistics Automotive, Consumer Goods Retail, Building Construction, and Agriculture.
Our core team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Human Resources, Bio-Technology, Medicine, Information Technology, Environmental Science, and more.
Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: rajat@renub.com
Website: www.renub.com
? Explore full report and detailed forecast: United States Diabetes Device Market
